{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T01:48:44Z","timestamp":1782611324013,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jiac.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T01:22:14Z","timestamp":1572744134000},"page":"280-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan"],"prefix":"10.1016","volume":"26","author":[{"given":"Kazuaki","family":"Tatara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohito","family":"Okumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Teramachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Shindou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.10.004_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2019.10.004_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2019.10.004_bib3","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/archinte.160.18.2819","article-title":"The incidence of antimicrobial allergies in hospitalized patients implications regarding prescribing patterns and emerging bacterial resistance","volume":"160","author":"Lee","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2019.10.004_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2180-12-215","article-title":"Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006)","volume":"12","author":"Rubio-L\u00f3pez","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jiac.2019.10.004_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0255-0857.136568","article-title":"Erythromycin resistant genes in group A \u03b2-haemolytic streptococci in chengdu, Southwestern China","volume":"32","author":"Zhou","year":"2014","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jiac.2019.10.004_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3201\/eid1809.120049","article-title":"Antimicrobial drug use and macrolide-resist Streptococcus pyogenes, Belgium","volume":"18","author":"Van Heirstraeten","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2019.10.004_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4920480a-89ff-479f-992d-8bda2bd599da","article-title":"Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece","volume":"8","author":"Syrogiannopoulos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2019.10.004_bib8","first-page":"90","article-title":"Drug susceptibility of bacteria isolated from pediatric respiratory infections at general practitioners\u2019 clinics to pediatric antibiotics","volume":"62","author":"Hirakata","year":"2009","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jiac.2019.10.004_bib9","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/AAC.46.10.3311-3315.2002","article-title":"Fluoroquinolone resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan","volume":"46","author":"Yokota","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.004_bib10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/AAC.44.4.840-847.2000","article-title":"Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae","volume":"44","author":"Ferrandiz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2019.10.004_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijantimicag.2009.01.012","article-title":"Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations","volume":"34","author":"Smeesters","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2019.10.004_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AAC.00780-09","article-title":"Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain","volume":"54","author":"Montes","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.004_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fmicb.2018.00542","article-title":"Identification and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes clones harboring tetracycline and macrolide resistance in Shanghai, China","volume":"23","author":"Shen","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2019.10.004_bib14","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/AAC.49.11.4798-4800.2005","article-title":"Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci","volume":"49","author":"Malhotra-Kumar","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.004_bib15","series-title":"Performance standards for antimicrobial susceptibility testing. 22nd informational supplement M100-S22","year":"2012"},{"key":"10.1016\/j.jiac.2019.10.004_bib16","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/IAI.69.4.2416-2427.2001","article-title":"Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone","volume":"69","author":"Enright","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2019.10.004_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1469-0691.2006.01408.x","article-title":"Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal","volume":"12","author":"Silva-Costa","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2019.10.004_bib18","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","article-title":"Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing","volume":"33","author":"Tenover","year":"1995","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2019.10.004_bib19","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/JCM.42.9.3998-4006.2004","article-title":"Molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999","volume":"42","author":"Chiou","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2019.10.004_bib20","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/AAC.44.11.3196-3198.2000","article-title":"Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: itification of gyrA and parC and Specification of point mutations associated with resistance","volume":"44","author":"Yan","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2019.10.004_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s15010-013-0440-0","article-title":"Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010","volume":"41","author":"Muraki","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2019.10.004_bib22","series-title":"Antimicrobial resistance surveillance in Europe","year":"2012"},{"issue":"2","key":"10.1016\/j.jiac.2019.10.004_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijantimicag.2007.04.001","article-title":"Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain","volume":"30","author":"Alonso","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiac.2019.10.004_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10096-013-1950-5","article-title":"Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy","volume":"33","author":"Petrelli","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:55Z","timestamp":1761159595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19303046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1341321X19303046"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}